| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SEAWELL A BROOKE | Director | C/O NVIDIA CORPORATION, 2788 SAN TOMAS EXPRESSWAY, SANTA CLARA | /s/ Rebecca Peters, Attorney-in-Fact for A. Brooke Seawell | 07 Jul 2025 | 0001197652 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVDA | Common Stock | Sale | $643,226 | -4,180 | -0.2% | $153.88 | 2,072,529 | 02 Jul 2025 | By Administrative Trust | F1, F2, F3, F4 |
| transaction | NVDA | Common Stock | Sale | $2,480,324 | -16,042 | -0.77% | $154.61 | 2,056,487 | 02 Jul 2025 | By Administrative Trust | F1, F4, F5 |
| transaction | NVDA | Common Stock | Sale | $1,459,537 | -9,379 | -0.46% | $155.62 | 2,047,108 | 02 Jul 2025 | By Administrative Trust | F1, F4, F6 |
| transaction | NVDA | Common Stock | Sale | $2,994,808 | -19,128 | -0.93% | $156.57 | 2,027,980 | 02 Jul 2025 | By Administrative Trust | F1, F4, F7 |
| transaction | NVDA | Common Stock | Sale | $422,024 | -2,682 | -0.13% | $157.35 | 2,025,298 | 02 Jul 2025 | By Administrative Trust | F1, F4, F8 |
| transaction | NVDA | Common Stock | Sale | $4,068,267 | -25,738 | -1.3% | $158.06 | 1,999,560 | 07 Jul 2025 | By Administrative Trust | F1, F4, F9 |
| transaction | NVDA | Common Stock | Sale | $3,931,604 | -24,776 | -1.2% | $158.69 | 1,974,784 | 07 Jul 2025 | By Administrative Trust | F1, F4, F10 |
| holding | NVDA | Common Stock | 10,387 | 02 Jul 2025 | Direct | ||||||
| holding | NVDA | Common Stock | 2,500,000 | 02 Jul 2025 | By Survivor Trust | F11, F12 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. |
| F2 | Represents weighted average sales price. The shares were sold at prices ranging from $153.195 to $154.190. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Includes 500,000 shares transferred without consideration from The A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Trust") to The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Administrative Trust"). |
| F4 | The shares are held by the Administrative Trust. |
| F5 | Represents weighted average sales price. The shares were sold at prices ranging from $154.200 to $155.190. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Represents weighted average sales price. The shares were sold at prices ranging from $155.200 to $156.190. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Represents weighted average sales price. The shares were sold at prices ranging from $156.200 to $157.190. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Represents weighted average sales price. The shares were sold at prices ranging from $157.200 to $157.590. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Represents weighted average sales price. The shares were sold at prices ranging from $157.395 to $158.390. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F10 | Represents weighted average sales price. The shares were sold at prices ranging from $158.400 to $159.200. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F11 | Includes 500,000 shares transferred without consideration from the Trust to The Alexander Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee (the "Survivor Trust"). |
| F12 | The shares are held by the Survivor Trust. |